S S Wasserman - JoVE Visualize

Showing results (71-80 of 79) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 79 results.

AIDS (London, England)|August 26, 1998

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.

Lancet (London, England)|November 22, 2001

Determinants of HIV-1 shedding in the genital tract of womenA Kovacs, S S Wasserman, D Burns, et al.

Vaccine|April 1, 1995

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.

Infection and Immunity|September 1, 1997

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and PeruD N Taylor, C O Tacket, G Losonsky, et al.

Infection and Immunity|November 24, 1999

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationC O Tacket, M B Cohen, S S Wasserman, et al.

Infection and Immunity|March 20, 1999

Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in PanamaD N Taylor, J L Sanchez, J M Castro, et al.

Infection and Immunity|February 26, 2000

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteersC O Tacket, M B Sztein, S S Wasserman, et al.

Vaccine|March 30, 2000

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic areaE E Richie, N H Punjabi, Y Y Sidharta, et al.

The American Journal of Tropical Medicine and Hygiene|January 27, 2004

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccinesN Kanesa-Thasan, R Edelman, C O Tacket, et al.

Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 79 results.

AIDS (London, England)|August 26, 1998

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.

Lancet (London, England)|November 22, 2001

Determinants of HIV-1 shedding in the genital tract of womenA Kovacs, S S Wasserman, D Burns, et al.

Vaccine|April 1, 1995

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.

Infection and Immunity|September 1, 1997

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and PeruD N Taylor, C O Tacket, G Losonsky, et al.

Infection and Immunity|November 24, 1999

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationC O Tacket, M B Cohen, S S Wasserman, et al.

Infection and Immunity|March 20, 1999

Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in PanamaD N Taylor, J L Sanchez, J M Castro, et al.

Infection and Immunity|February 26, 2000

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteersC O Tacket, M B Sztein, S S Wasserman, et al.

Vaccine|March 30, 2000

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic areaE E Richie, N H Punjabi, Y Y Sidharta, et al.

The American Journal of Tropical Medicine and Hygiene|January 27, 2004

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccinesN Kanesa-Thasan, R Edelman, C O Tacket, et al.

Pageof 8